(Q48315834)
Statements
1 reference
Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: results of a randomized phase IIb/III trial (LUX-Lung 1). (English)
1 reference
1 reference
Diane Fairclough
1 reference
Vera Hirsh
1 reference
Jacques Cadranel
1 reference
Xiuyu Julie Cong
1 reference
Henrik W Finnern
1 reference
Robert M Lorence
1 reference
Vince A Miller
1 reference
Michael Palmer
1 reference
1 February 2013
1 reference
8
1 reference
2
1 reference
229-237
1 reference